FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Brigitte Tranchand

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Disorders

Phenomena

Metabolic Clearance Rate

Co-author Network

Publications

TOP 3
Eddy Cotte; Olivier Colomban; Jérome Guitton; Brigitte Tranchand; Nawel Bakrin; François Noël Gilly; Olivier Glehen; Michel Tod
Population pharmacokinetics and pharmacodynamics of cisplatinum during hyperthermic intraperitoneal chemotherapy using a closed abdominal procedure.
Benoit You; Ludivine Fronton; Helen Boyle; Jean-Pierre Droz; Pascal Girard; Brigitte Tranchand; Benjamin Ribba; Michel Tod; Sylvie Chabaud; Henri Coquelin; Aude Fléchon
Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
B You; M Pollet-Villard; L Fronton; C Labrousse; Anne-Marie Schott; Touria Hajri; P Girard; Gilles Freyer; M Tod; Brigitte Tranchand; O Colomban; Benjamin Ribba; Daniel Raudrant; J Massardier; Sylvie Chabaud; F Golfier
Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasias.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Brigitte Tranchand (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Eddy Cotte; Olivier Colomban; Jérome Guitton; Brigitte Tranchand; Nawel Bakrin; François Noël Gilly; Olivier Glehen; Michel Tod
Population pharmacokinetics and pharmacodynamics of cisplatinum during hyperthermic intraperitoneal chemotherapy using a closed abdominal procedure.
Journal of clinical pharmacology 2011;51(1):9-18.
2010: Benoit You; Ludivine Fronton; Helen Boyle; Jean-Pierre Droz; Pascal Girard; Brigitte Tranchand; Benjamin Ribba; Michel Tod; Sylvie Chabaud; Henri Coquelin; Aude Fléchon
Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
Urology 2010;76(2):423-9.e2.
2010: B You; M Pollet-Villard; L Fronton; C Labrousse; Anne-Marie Schott; Touria Hajri; P Girard; Gilles Freyer; M Tod; Brigitte Tranchand; O Colomban; Benjamin Ribba; Daniel Raudrant; J Massardier; Sylvie Chabaud; F Golfier
Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasias.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(8):1643-50.
2009: Emilie Hénin; Michel Tod; Véronique Trillet-Lenoir; Catherine Rioufol; Brigitte Tranchand; Pascal Girard
Pharmacokinetically based estimation of patient compliance with oral anticancer chemotherapies: in silico evaluation.
Clinical pharmacokinetics 2009;48(6):359-69.
2008: Benoit You; Brigitte Tranchand; Pascal Girard; Claire Falandry; Benjamin Ribba; Sylvie Chabaud; Pierre-Jean Souquet; Isabelle Court-Fortune; Véronique Trillet-Lenoir; Cécile Fournel; Michel Tod; Gilles Freyer
Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
Lung cancer (Amsterdam, Netherlands) 2008;62(2):261-72.
2008: Benoit You; Paul Perrin; Gilles Freyer; Alain Ruffion; Brigitte Tranchand; Emilie Hénin; Philippe Paparel; Benjamin Ribba; Marian Devonec; Claire Falandry; Cécile Fournel; Michel Tod; Pascal Girard
Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomy.
Clinical biochemistry 2008;41(10-11):785-95.
2008: Brigitte Tranchand; Claire Falandry; Benoît You; Pascale Girard; Benjamin Ribba; Michael Tod; Gilles Freyer
[Pharmacology of anticancer drugs in the elderly: tools for dose-adjustment].
Bulletin du cancer 2008;95 FMC Onco():F21-7.
2007: Markus Joerger; Alwin D R Huitema; Dick J Richel; Christian Dittrich; Nicholas Pavlidis; Evangelos Briasoulis; Jan B Vermorken; Elena Strocchi; Andrea Martoni; Roberto Sorio; Henk P Sleeboom; Miguel A Izquierdo; Duncan I Jodrell; Hilary Calvert; Alan V Boddy; Harry Hollema; Regine Féty; Wjf J F Van der Vijgh; Georg Hempel; Etienne Chatelut; Mats Karlsson; Justin Wilkins; Brigitte Tranchand; Ad H G J Schrijvers; Chris Twelves; Jos H Beijnen; Jan H M Schellens
Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(21):6410-8.
2007: Céline Dartois; Karl Brendel; Emmanuelle Comets; Céline M Laffont; Christian Laveille; Brigitte Tranchand; France Mentré; Annabelle Lemenuel-Diot; P Girard
Overview of model-building strategies in population PK/PD analyses: 2002-2004 literature survey.
British journal of clinical pharmacology 2007;64(5):603-12.
2007: A Berges; S Laporte; Magali Epinat; Paul Zufferey; E Alamartine; Brigitte Tranchand; Hervé Decousus; Patrick Mismetti
Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years old.
British journal of clinical pharmacology 2007;64(4):428-38.
2007: Diane Testart-Paillet; Pascal Girard; Benoit You; Gilles Freyer; Christian Pobel; Brigitte Tranchand
Contribution of modelling chemotherapy-induced hematological toxicity for clinical practice.
Critical reviews in oncology/hematology 2007;63(1):1-11.
2007: Céline Dartois; Annabelle Lemenuel-Diot; Christian Laveille; Brigitte Tranchand; Michel Tod; Pascal Girard
Evaluation of uncertainty parameters estimated by different population PK software and methods.
Journal of pharmacokinetics and pharmacodynamics 2007;34(3):289-311.
2007: Stuart M Lichtman; Hans Wildiers; Etienne Chatelut; Christopher Steer; Daniel R Budman; Vicki A Morrison; Brigitte Tranchand; Iuliana Shapira; Matti Aapro
International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(14):1832-43.
2007: Emilie Hénin; Benoit You; Brigitte Tranchand; Gilles Freyer; Pascal Girard
[Issues of the study of patient compliance to treatment with oral anticancer chemotherapy: advantages of pharmacokinetics-pharmacodynamics modelisation].
Thérapie 2007;62(2):77-85.
2007: Markus Joerger; Alwin D R Huitema; Dick J Richel; Christian Dittrich; Nikolas Pavlidis; Evangelos Briasoulis; Jan B Vermorken; Elena Strocchi; Andrea Martoni; Roberto Sorio; Henk P Sleeboom; Miguel A Izquierdo; Duncan I Jodrell; Régine Féty; Ernst de Bruijn; Georg Hempel; Mats Karlsson; Brigitte Tranchand; Ad H G J Schrijvers; Chris Twelves; Jos H Beijnen; Jan H M Schellens
Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDG.
Clinical pharmacokinetics 2007;46(12):1051-68.
2007: Céline Dartois; Gilles Freyer; Mauricette Michallet; Emilie Hénin; Benoît You; Isabelle Darlavoix; Claudine Vermot-Desroches; Brigitte Tranchand; Pascal Girard
Exposure-effect population model of inolimomab, a monoclonal antibody administered in first-line treatment for acute graft-versus-host disease.
Clinical pharmacokinetics 2007;46(5):417-32.
2007: Karl Brendel; Céline Dartois; Emmanuelle Comets; Annabelle Lemenuel-Diot; Christian Laveille; Brigitte Tranchand; Pascal Girard; Céline M Laffont; France Mentré
Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004.
Clinical pharmacokinetics 2007;46(3):221-34.
2006: Sébastien Salas; Cedric Mercier; Joseph Ciccolini; Bertrand Pourroy; Raphaelle Fanciullino; Brigitte Tranchand; Suzanne Monjanel-Mouterde; Marjorie Baciuchka-Palmaro; Charlotte Dupuis; Chenguang Yang; Medhi Balti; Bruno Lacarelle; Florence Duffaud; Alain Durand; Roger Favre
Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma.
Therapeutic drug monitoring 2006;28(4):532-9.
2006: Cedric Mercier; Joseph Ciccolini; Bertrand Pourroy; Raphaelle Fanciullino; Florence Duffaud; Laurence Digue; Brigitte Tranchand; Suzanne Monjanel-Mouterde; Pierre Guillet; Adriana Nicoara; Marjorie Baciuchka; Danielle Bagarry-Liegey; Bruno Lacarelle; Alex Noble; Alain Durand; Roger Favre
Dose individualization of carboplatin after a 120-hour infusion schedule: higher dose intensity but fewer toxicities.
Therapeutic drug monitoring 2006;28(2):212-8.
2005: Jérôme Guitton; S Cohen; Brigitte Tranchand; B Vignal; J-P Droz; M Guillaumont; M Manchon; Gilles Freyer
Quantification of docetaxel and its main metabolites in human plasma by liquid chromatography/tandem mass spectrometry.
Rapid communications in mass spectrometry : RCM 2005;19(17):2419-26.
2003: Brigitte Tranchand; Silvy Laporte; Olivier Glehen; Gilles Freyer
Pharmacology of cytotoxic agents: a helpful tool for building dose adjustment guidelines in the elderly.
Critical reviews in oncology/hematology 2003;48(2):199-214.
2003: C Dumontet; Jérôme Jaubert; Catherine Sebban; F Bouafia; Claude Ardiet; Brigitte Tranchand; E Berger; C Lucas; Denis Guyotat; Bertrand Coiffier
Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(4):615-22.
2002: Cécile Vigneau; Claude Ardiet; Monique Bret; Martine Laville; Denis Fiere; Brigitte Tranchand; Denis Fouque
Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure.
Journal of nephrology 2002;15(6):684-9.
2002: Philippe Variol; Laurent Nguyen; Brigitte Tranchand; Christian Puozzo
A simultaneous oral/intravenous population pharmacokinetic model for vinorelbine.
European journal of clinical pharmacology 2002;58(7):467-76.
2002: Laurent Nguyen; Brigitte Tranchand; Christian Puozzo; Philippe Variol
Population pharmacokinetics model and limited sampling strategy for intravenous vinorelbine derived from phase I clinical trials.
British journal of clinical pharmacology 2002;53(5):459-68.
2001: Gilles Vassal; Brigitte Tranchand; Dominique Valteau-Couanet; Cédric Mahé; Dominique Couanet; C Schoeppfer; jacques grill; Chantal Kalifa; Catherine Hill; Claude Ardiet; Olivier Hartmann
Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma.
Bone marrow transplantation 2001;27(5):471-7.
2001: Gilles Freyer; Blandine Ligneau; Brigitte Tranchand; Claude Ardiet; Pierre-Jean Souquet; I Court-Fortune; R Riou; Paul Rebattu; E Morignat; J P Boissel; Véronique Trillet-Lenoir; P Girard
The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients: a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT).
Lung cancer (Amsterdam, Netherlands) 2001;31(2-3):247-56.
2000: Gilles Freyer; Brigitte Tranchand; Blandine Ligneau; Claude Ardiet; Pierre-Jean Souquet; I Court-Fortune; R Riou; Paul Rebattu; J P Boissel; Véronique Trillet-Lenoir; P Girard
Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study.
British journal of clinical pharmacology 2000;50(4):315-24.
1999: Claude Ardiet; Brigitte Tranchand; S Zanetta; A Guillot; E Bernard; M Peguy; Paul Rebattu; Jean Pierre Droz
A sensitive docetaxel assay in plasma by solid-phase extraction and high performance liquid chromatography-UV detection: validation and suitability in phase I clinical trial pharmacokinetics.
Investigational new drugs 1999;17(4):325-33.
1999: Brigitte Tranchand; C Amsellem; Etienne Chatelut; Gilles Freyer; Athanassios Iliadis; Blandine Ligneau; Véronique Trillet-Lenoir; Pierre Canal; Isabelle Lochon; Claude Ardiet
A limited-sampling strategy for estimation of etoposide pharmacokinetics in cancer patients.
Cancer chemotherapy and pharmacology 1999;43(4):316-22.
1998: Brigitte Tranchand; Gilles Catimel; C Lucas; M Sarkany; G Bastian; E Evene; Jean-Paul Guastalla; Sylvie Négrier; Paul Rebattu; Arlette Dumortier; M Foy; F Grossin; B Mazier; M Froudarakis; N Barbet; MD Clavel; Claude Ardiet
Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 1998;41(4):281-91.
1998: L Nguyen; Etienne Chatelut; Christine Chevreau; Brigitte Tranchand; Isabelle Lochon; Jean-Marc Bachaud; A Pujol; G Houin; Roland Bugat; Pierre Canal
Population pharmacokinetics of total and unbound etoposide.
Cancer chemotherapy and pharmacology 1998;41(2):125-32.
1997: E Evene; Etienne Chatelut; Brigitte Tranchand; Pierre Canal; Isabelle Lochon; Athanassios Iliadis; Claude Ardiet
[Bayesian estimation of pharmacokinetic parameters of etoposide].
Bulletin du cancer 1997;84(7):699-703.
1997: Gilles Freyer; Blandine Ligneau; Brigitte Tranchand; Claude Ardiet; F Serre-Debeauvais; Véronique Trillet-Lenoir
Pharmacokinetic studies in cancer chemotherapy: usefulness in clinical practice.
Cancer treatment reviews 1997;23(3):153-69.
1996: Athanassios Iliadis; M C Launay-Iliadis; C Lucas; R Fety; F Lokiec; Brigitte Tranchand; G Milano
Pharmacokinetics and pharmacodynamics of nitrosourea fotemustine: a French cancer centre multicentric study.
European journal of cancer (Oxford, England : 1990) 1996;32A(3):455-60.
1995: Gilles Freyer; P Maire; Claude Ardiet; Brigitte Tranchand; J P Droz
[Cytotoxic chemotherapy in elderly patients: present and future].
Bulletin du cancer 1995;82(7):531-40.
1995: L Dirix; Gilles Catimel; R Verdonk; E De Bruijn; Brigitte Tranchand; Claude Ardiet; A Van Oosterom
Phase I and pharmacokinetic study of KW-2149 given by 24 hours continuous infusion.
Investigational new drugs 1995;13(2):133-6.
1994: Brigitte Tranchand; Claude Ardiet; E Bouffet; P Biron; I Philip; F Nasri; M Brunat-Mentigny
[Effect of carboplatin on the pharmacokinetics of melphalan administered intravenously].
Bulletin du cancer 1994;81(1):43-6.
1993: Brigitte Tranchand; C Lucas; P Biron; B Giroux; B Gordon; R Richards; P Solere; N Roux; E Evene; F Mornex
Phase I pharmacokinetics study of high-dose fotemustine and its metabolite 2-chloroethanol in patients with high-grade gliomas.
Cancer chemotherapy and pharmacology 1993;32(1):46-52.
1992: D Y Ploin; Brigitte Tranchand; Jean-Paul Guastalla; Paul Rebattu; F Chauvin; M Clavel; Claude Ardiet
Pharmacokinetically guided dosing for intravenous melphalan: a pilot study in patients with advanced ovarian adenocarcinoma.
European journal of cancer (Oxford, England : 1990) 1992;28A(8-9):1311-5.
1992: B Bally; JEAN-FRANCOIS PAYEN DE LA GARANDERIE; F Serre-Debeauvais; Brigitte Tranchand; M Gavend; P Stieglitz
[Pharmacokinetics of methohexital given by constant rate intravenous infusion].
Annales françaises d'anesthèsie et de rèanimation 1992;11(2):136-40.
1990: F Serre-Debeauvais; Athanassios Iliadis; Brigitte Tranchand; M Michallet; S Benzekri; Claude Ardiet; J P Cano; M Hollard; M Gavend
Bayesian estimation of cyclosporine clearance in bone marrow graft.
Therapeutic drug monitoring 1990;12(1):16-22.
1989: Brigitte Tranchand; Y D Ploin; M P Minuit; C Sapet; P Biron; T Philip; Claude Ardiet
High-dose melphalan dosage adjustment: possibility of using a test-dose.
Cancer chemotherapy and pharmacology 1989;23(2):95-100.
1989: C Sapet; Brigitte Tranchand; C Navarro; Claude Ardiet
[Cellular pharmacokinetics of melphalan alone or in combination on human lymphoma or lymphoblasts].
Bulletin du cancer 1989;76(8):875-7.
1989: Brigitte Tranchand; F Nasri; M Minuit; M Clavel; Jean-Paul Guastalla; S Gamand; Claude Ardiet
[Phase I pharmacokinetics of flavone-acetic acid].
Bulletin du cancer 1989;76(8):871-4.
1988: Brigitte Tranchand; P Biron; A Mercatello; T Philip; Claude Ardiet
[Pharmacokinetics of high-dose melphalan (200 mg/m2) in a case of total renal insufficiency].
Bulletin du cancer 1988;75(3):291-6.
1986: Claude Ardiet; Brigitte Tranchand; P Biron; Paul Rebattu; T Philip
Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis. Report in 26 cases.
Cancer chemotherapy and pharmacology 1986;16(3):300-5.